Differential effects of two ROCK inhibitors, Fasudil and Y-27632, on optic nerve regeneration in adult cats

Brain Res. 2008 Mar 27:1201:23-33. doi: 10.1016/j.brainres.2008.01.063. Epub 2008 Feb 5.

Abstract

A ROCK inhibitor Fasudil is widely administered to relieve vasospasm in patients after subarachnoid hemorrhage in Japan. We investigated the difference of Fasudil and Y-27632, a common ROCK inhibitor, on neurite regeneration in culture and axonal regeneration after injuring the optic nerve (OpN) in cats. The optimal dose of Y-27632, determined by counting the number and length of neurites in retinal explants, was found to be 100 microM: the only effect of Fasudil was to promote extension of glial processes. We next examined the effects of Fasudil (10 microM-100 microM) and Y-27632 (10 microM-300 microM) on axonal regeneration in the crushed OpN model in vivo. Immediately after crushing the left OpN, Fasudil or Y-27632 was injected into the vitreous and the crushed site. Injection of 10 microM and 100 microM Y-27632 induced extension of the optic axons beyond the crush site, with the latter dosage giving stronger regeneration. Very few axons passed beyond the crush site in the optic nerve with phosphate-buffered saline injection, and no axons elongated in the OpN with Fasudil injection.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives*
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / therapeutic use
  • Amides / pharmacology*
  • Amides / therapeutic use
  • Animals
  • Axons / drug effects
  • Axons / enzymology
  • Axons / pathology
  • Cats
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Female
  • Male
  • Nerve Crush
  • Nerve Regeneration / drug effects*
  • Nerve Regeneration / physiology
  • Optic Nerve / drug effects
  • Optic Nerve / enzymology
  • Optic Nerve / physiopathology
  • Optic Nerve Injuries / drug therapy*
  • Optic Nerve Injuries / enzymology
  • Optic Nerve Injuries / physiopathology
  • Organ Culture Techniques
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use
  • Pyridines / pharmacology*
  • Pyridines / therapeutic use
  • Retina / cytology
  • Retina / drug effects
  • Treatment Outcome
  • Wallerian Degeneration / drug therapy
  • Wallerian Degeneration / enzymology
  • Wallerian Degeneration / physiopathology
  • rho-Associated Kinases / antagonists & inhibitors*
  • rho-Associated Kinases / metabolism

Substances

  • Amides
  • Enzyme Inhibitors
  • Protein Kinase Inhibitors
  • Pyridines
  • Y 27632
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • rho-Associated Kinases
  • fasudil